InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（7 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Cardoza George, 首席财务官. Director active across 2 companies, notably SOPHiA GENETICS SA. In total, 13 reports have been recorded. Breakdown: 1 buy · 7 sells. Total volume traded: €5.7m. Activity tracked since 2 June 2021. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cardoza George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
1,592 股@ US$5.28860.0019% mcap7.9% 占其流量Ordinary SharesSEC:0001840706-26-000253:0
774 股Ordinary SharesSEC:0001840706-26-000228:0
20,000 股@ US$4.950.018% mcap100.0% 占其流量Ordinary SharesSEC:0001840706-26-000205:0
标准退出：2026年9月3日 (T+90)
1,403 股@ US$4.84724.9% 占其流量Ordinary SharesSEC:0001840706-26-000136:0
112,936 股0Ordinary SharesSEC:0001840706-26-000108:0
2,520 股@ US$4.84568.9% 占其流量Ordinary SharesSEC:0001840706-26-000123:0
2,413 股@ US$4.87718.5% 占其流量Ordinary SharesSEC:0001840706-26-000123:1
112,936 股0Ordinary SharesSEC:0001840706-26-000086:0
774 股@ US$4.78622.6% 占其流量Ordinary SharesSEC:0001840706-26-000064:0
503 股0Common StockSEC:0001077183-22-000041:0
61,143 股0Common StockSEC:0001077183-21-000277:0
7,584 股0Common StockSEC:0001077183-21-000187:0
169,230 股@ US$40.39100.0% 占其流量Common StockSEC:0001077183-21-000155:0
13 条申报中的 13 条
About Cardoza George
George Cardoza is the Chief Financial Officer and President of Pharma Services at SOPHiA GENETICS SA and NEOGENOMICS INC. In this role, he oversees the financial and strategic operations of both companies. Cardoza plays a key role in guiding financial strategy and managing resources to ensure growth and innovation. His expertise is essential for the success of both organizations.
